Der Ultimative Calyptemotivationsthread

Calypte Biomedical Corporation Delayed: Jun 24 10:28 AM EDT

CYPT 0.56    0.02  

Today 5 Dy 1 Mo 3 Mo 1 Yr 5 Yr
Last Price  
0.56
Change $
0.02  
Change %
3.7%  
Tick
   

Bid
0.55
Bid Size
2500
Ask
0.57
Ask Size
2500

Open
0.54
High
0.56
Low
0.535
Prev Close
0.54

Last Trade
10:29
Volume  
181.6 k
52 Wk Hi
1.799
52 Wk Lo
0.104

Market Cap
78.51 m
Ex-Div Date
N/A
Dividend
N/A
Yield
N/A

Shares
140.2 m
EPS (TTM)
-6.20
PE Ratio
N/A
 


 

Samui ist meine 2. Heimat, geh mal ins Blue Marlin und iss einen red snapper ! Sind die Schlampen immer noch so haesslich ?  

Calypte Biomedical Corp. (ticker: CYPT.OB, exchange: Other OTC) News Release - 24-Jun-2004


--------------------------------------------------
Calypte's Rockville, Maryland Facility Receives Quality System Certification to ISO 13485:1996

Corporate Headquarters Moved to Pleasanton, California
PLEASANTON, Calif., Jun 24, 2004 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CYPT), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that its Rockville, Maryland manufacturing facility has successfully passed its quality system audit to obtain certification of its quality system to the international standard, ISO 13485:1996. A comprehensive, two-day examination against the requirements of the ISO 13485 standard was conducted by an independent auditor.

The ISO 13485 standard specifically addresses the application of quality system principles to medical device products. Regulatory authorities in several countries around the world such as US FDA, Health Canada, China, the European Union and others base their requirements for good manufacturing practices (GMP) on the ISO quality standards. In Canada, conformance to ISO 13485 is a specific requirement for the maintenance of Calypte's approval for the Cambridge Biotech HIV-1 Western Blot product. Conformance to the ISO standards is also one of the many requirements upon which compliance with the European Union Medical Device and In Vitro Diagnostics Directives and CE Marking rests.

Calypte's Rockville plant holds a biological license approval and PMA approval from the US FDA for the company's HIV-1 Western Blot tests and houses a Biosafety Level 3 laboratory for the production of HIV-1 viral materials. The company is actively transferring the manufacture of its PMA approved HIV-1 Urine EIA test into the Rockville facility.

J. Richard George, Calypte's President and Chief Executive Officer, explained, "This is the first ISO quality inspection of our Rockville facility and we are extremely pleased that GMED has granted Calypte certification to ISO 13485. Our on-going company-wide commitment to quality continues and we believe that obtaining this certification positions us well to maintain our presence in the international diagnostics market and to allow us to expand into areas of the world that utilize the ISO standards as a key regulatory requirement. We believe that we continue to have the systems in place that allow us to produce the high quality products our customers around the world have come to expect."

The Company expects to realize on-going savings of approximately $1 million per year in personnel and occupancy expense as a result of the closure of its previously ISO certified facility in Alameda, California and the transfer of manufacturing operations to the Rockville, Maryland location. As part of this transfer, Calypte has relocated its corporate headquarters to: 5000 Hopyard Road, Suite 480, Pleasanton, California 94588, 925-730-7200.

About Calypte Biomedical:

Calypte Biomedical Corporation, headquartered in Pleasanton California, is a public healthcare company dedicated to the development and commercialization of in vitro diagnostic tests, primarily for the detection of antibodies to Human Immunodeficiency Virus (HIV), and other sexually transmitted and infectious diseases. Calypte's currently marketed laboratory-based tests include an enzyme immunoassay (EIA) HIV-1 antibody screening test and an HIV-1 antibody western blot supplemental test, the only two FDA-approved HIV-1 antibody tests for use on urine samples, as well as an FDA-approved serum HIV- 1 antibody western blot supplemental test. Calypte is actively engaged in developing new test products for the rapid detection of HIV and other infectious diseases. Calypte believes that there is a significant need for rapid detection of such diseases globally to control their proliferation, particularly in lesser-developed countries, which lack the medical infrastructure to support laboratory-based testing. Calypte believes that testing for HIV and other infectious diseases may make important contributions to public health.

Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing and access funds from its existing financing arrangements that will allow it to continue its current and future operations and whether demand for its test products in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-KSB for the year ended December 31, 2003 and its subsequent filings with the SEC.

 

 

weiterentwickelt was das Zeug hält, jetzt nach den News zufolge auch noch eine ISO-Zertifizierung. Es ist nur noch eine Frage der Zeit, wann es endlich mal News zu Aquisitationen gibt, dann geht das Ding durch die Decke. Vor einem Jahr hat die Phantasie schon den Kurs bis fast 2 Dollar getrieben, was passiert wohl, wenn da wirklich ein Absatzmarkt da ist, der dann auch bestätigt wird, oh je. Ich rate nur jedem zu halten, wenn er auf long-Basis bei Caly investiert ist.

Man schau mal Kandidaten wie 8x8 (EGHT) oder Biocurex (BOCX) an, 8x8 explodierte innerhalb von 4 Monaten von 0,50 § auf 8,00 $, oder Biocurex innerhalb von 2 Wochen von 0,25 $ auf 3,50 $, Wahnsinn. Hier mal die Chars, nur mal zum anschauen:

8x8 (1-Jahr-Sicht):

Biocurex (1-Jahr-Sicht):

 

bin ich der festen überzeugung, das es insider gibt die mehr wissen.ist zwar nicht so schön das sowas bei caly läuft, aber so lange die kaufen solls mir recht sein.da werden wir viel geld mit verdienen.grins  

gut aus.Taxe bei 0,56bid-0,57ask.das bid bei 0,55 wurde gestern ganz gut ausgebaut.;O)  

 

 

was soll man davon halten??strohfeuer, insiderkäufe oder einfach nur vermehrtes interesse??fragezeichen, fragezeichen.  

 

traut sich wohl keiner so recht.bin gespannt was heute passiert.letzte woche sinds in amiland schließlich um die 30% plus gewesen.hi biomedi.  

grünen pfeile bedeuten, wenn man bei der otc ins orderbuch schaut?danke schonmal
MMD  Bid Bid Size
SBSH ↑  0.600 25
SCHB ↑  0.600 25
WIEN ↑  0.600 25
HILL ↑  0.590 25
TDCM ↑  0.590 25
VERT ↑  0.580 25
GVRC ↑  0.575 25
BAMM ↑  0.550 25
CRWN ↑  0.550 25
NITE ↑  0.550 25
OPCO ↑  0.550 25
JEFF ↑  0.535 25
EFGI ↑  0.530 25
FRAN ↑  0.510 25
VFIN ↑  0.510 25
 

denke mal das bedeutet, dass diese Stücke dann aus dem Ask gekauft wurden, somit würde dann ein roter Pfeil bedeuten, dass die Stücke ins Bid geschmissen wurden. Was ich nicht kapiere, was die Zeichen bedeuten SBSH, SCHB, HILL etc. Was bedeuten diese ??  

danke für die antwort börsenfan.  

bin seid heute wieder im Lande war in Bulgarien Goldstrand
Viele Grüße an Alle, Lucky  

 

Es ist was im Busch, spätestens morgen gute News. Das Volumen in USA ist in den ersten 20 Minuten so hoch wie vorletzte Woche am ganzen Tag. Ich tippe auf den ersten Grossauftrag durch die WHO  

 

über 0,60$ füllt sich langsam. ;O)  

Da muss was kommen und dann geht die Aktie durch die Decke. Schaut euch mal die Umsatze in Frankfurt an..  

 

einer woche.rätseln ist angesagt.glaube langsam da wissen welche mehr.und kaum einer schmeißt stücke ins bid.lol.immer gespannter bin.habe noch was flüssiges liegen, was ich einsetze, wenn ne goile news kommen sollte.wenn. ;O)  

könnte einen hinweis sein, ob evtl. morgen was kommt.  

da hat es insider a gogo